Consun Pharmaceutical Group Limited

Consun Pharmaceutical Group Limitedverified

1681.HK

Price:

$16.15

Market Cap:

$12.41B

Consun Pharmaceutical Group Limited, an investment holding company, researches and develops, manufactures, and sells Chinese medicines and medical contrast medium products in the People's Republic of China. The company operates through two segments, Consun Pharmaceutical and Yulin Pharmaceutical. It offers uremic clearance granule to treat chronic kidney diseases; Yishen Huashi particles to treat proteinuria; Gadopentetate Dimeglumine injections for magnetic resonance image diagnostics of nervous centralis, stomach, chest, pelvic cavity, and extremities, as well as for renal function assessment; and Iopamidol injections used for neuroradiology, angiography, and urography. The company also pr...[Read more]

Industry

Drug Manufacturers - Specialty & Generic

IPO Date

2013-12-19

Stock Exchange

HKSE

Ticker

1681.HK

The ROE as of December 2025 (TTM) for Consun Pharmaceutical Group Limited (1681.HK) is 23.89%

According to Consun Pharmaceutical Group Limited’s latest financial reports and current stock price. The company's current ROE is 23.89%. This represents a change of 104.35% compared to the average of 11.69% of the last 4 quarters.

Consun Pharmaceutical Group Limited (1681.HK) Historical ROE (quarterly & annually)

How has 1681.HK ROE performed in the past?

The mean historical ROE of Consun Pharmaceutical Group Limited over the last ten years is 19.16%. The current 23.89% ROE has changed 24.70% with respect to the historical average. Over the past ten years (40 quarters), 1681.HK's ROE was at its highest in in the June 2013 quarter at 14.26%. The ROE was at its lowest in in the December 2019 quarter at -8.51%.

Quarterly (TTM)
Annual

Average

19.16%

Median

21.67%

Minimum

4.00%

Maximum

22.69%

Consun Pharmaceutical Group Limited (1681.HK) ROE by Quarter and Year

Discovering the peaks and valleys of Consun Pharmaceutical Group Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 461.21%

Maximum Annual ROE = 22.69%

Minimum Annual Increase = -81.44%

Minimum Annual ROE = 4.00%

Quarterly (TTM)
Annual
YearROEChange
202422.22%2.71%
202321.63%-0.37%
202221.71%-3.69%
202122.55%0.36%
202022.46%461.21%
20194.00%-81.44%
201821.57%-4.91%
201722.69%29.87%
201617.47%14.51%
201515.26%3.52%

Consun Pharmaceutical Group Limited (1681.HK) Average ROE

How has 1681.HK ROE performed in the past?

The current ROE of Consun Pharmaceutical Group Limited (1681.HK) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

21.86%

5-year avg

22.12%

10-year avg

19.16%

Consun Pharmaceutical Group Limited (1681.HK) ROE vs. Peers

How is 1681.HK’s ROE compared to its peers?

Consun Pharmaceutical Group Limited’s ROE is less than Shandong Xinhua Pharmaceutical Company Limited (7.49%), greater than China Traditional Chinese Medicine Holdings Co. Limited (-1.26%), greater than Sihuan Pharmaceutical Holdings Group Ltd. (-1.84%), less than SSY Group Limited (9.09%), less than Luye Pharma Group Ltd. (2.75%), less than Shanghai Haohai Biological Technology Co., Ltd. (6.84%), greater than Ab&B Bio Tech Co Ltd. (-251.71%), less than Kangji Medical Holdings Limited (21.49%), less than Angelalign Technology Inc. (4.98%), less than Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (3.43%),

Build a custom stock screener for Consun Pharmaceutical Group Limited (1681.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Consun Pharmaceutical Group Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Consun Pharmaceutical Group Limited (1681.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Consun Pharmaceutical Group Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the ROE?

How can you use the ROE?

What is Consun Pharmaceutical Group Limited's ROE?

How is the ROE calculated for Consun Pharmaceutical Group Limited (1681.HK)?

What is the highest ROE for Consun Pharmaceutical Group Limited (1681.HK)?

What is the 3-year average ROE for Consun Pharmaceutical Group Limited (1681.HK)?

What is the 5-year average ROE for Consun Pharmaceutical Group Limited (1681.HK)?

How does the current ROE for Consun Pharmaceutical Group Limited (1681.HK) compare to its historical average?